Incidence of Neoplastic Disease in Cardiac Allograft Recipients

被引：2
作者：
Savasta, Marcello [1 ]
Lentini, Salvatore [1 ]
机构：
[1] Univ Messina, Policlin G Martino Univ Hosp, Cardiovasc & Thorac Dept, I-98100 Messina, Italy
来源：
REVIEWS IN CARDIOVASCULAR MEDICINE | 2011年 / 12卷 / 04期
关键词：
Immunology; Heart transplantation; Surgery complications; Tumor; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; SOLID-ORGAN TRANSPLANTATION; RENAL-TRANSPLANTATION; HEART-TRANSPLANTATION; SKIN-CANCER; IMMUNOSUPPRESSIVE AGENTS; ALEMTUZUMAB CAMPATH-1H; MALIGNANCIES; EXPERIENCE; TACROLIMUS;
D O I：
10.3909/ricm0582
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Incidence of neoplastic disease represents a serious complication after heart transplantation. In this review, the authors discuss the incidence, causes, and types of tumors in cardiac allograft recipients. Prevention and tumor monitoring for early treatment are highlighted. [Rev Cardiovasc Med. 2011;12(4):219-226 doi: 10.3909/ricm0582 (C) 2011 MedReviews (R), LLC
引用
收藏
页码：219 / 226
页数：8
相关论文
共 52 条
[51]   The effects of FK778 in combination with tacrolimus and steroids:: A phase II Multicenter study in renal transplant patients [J].
Vanrenterghem, Y ;
van Hooff, JP ;
Klinger, M ;
Wlodarczyk, Z ;
Squifflet, JP ;
Mourad, G ;
Neuhaus, P ;
Jurewicz, A ;
Rostaing, L ;
Charpentier, B ;
Paczek, L ;
Kreis, H ;
Chang, R ;
Paul, LC ;
Grinyó, JM ;
Short, C .
TRANSPLANTATION, 2004, 78 (01) :9-14
[52]   Lymphoproliferative Disorders After Solid Organ Transplantation-Classification, Incidence, Risk Factors, Early Detection and Treatment Options [J].
Vegso, Gyula ;
Hajdu, Melinda ;
Sebestyen, Anna .
PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (03) :443-454
123456